EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Profiling of five urinary exosomal miRNAs for the differential diagnosis of patients with diabetic kidney disease and focal segmental glomerulosclerosis

Sinan Trabulus iD, Mehmet Seyit Zor, Selma Alagoz, Mevlut Tamer Dincer, Meral Meşe, Erkan Yilmaz, Eda Tahir Turanli, Nurhan Seyahi

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0312470 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Sinan Trabulus und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental, MicroRNAs, Diabetic Nephropathies, Exosomes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul Üniversitesi-Cerrahpasa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study is to investigate the diagnostic utility of microRNAs (miRNAs) for distinguishing between urine samples from patients with Diabetic Kidney Disease (DKD) and those with Focal Segmental Glomerulosclerosis (FSGS).

Methods

In this multicentric, cross-sectional investigation, we enrolled patients diagnosed with DKD, individuals with primary biopsy-proven FSGS, and healthy controls. The top 5 miRNAs (hsa-mir-21, hsa-mir-30a, hsa-mir-193a, hsa-mir-196a, hsa-mir-200a) were selected to quantify miRNAs in urine samples. Isolation of targeted miRNAs was performed from urinary exosomes, and the quantitative profile of the isolated miRNAs was measured by RT-qPCR. The ΔΔCt method was implemented to calculate the fold differences between disease and control samples.

Results

Thirteen DKD patients, 11 FSGS patients, and 14 healthy controls were included in this study. Hsa-mir-21 and hsa-mir-30a exhibited distinct regulation in both groups, with upregulation observed in FSGS and downregulation in DKD (hsa-mir-21 in DKD (0.668 ± 0.25, p < 0.0005) and FSGS (2.267 ± 1.138, p < 0.0077); hsa-mir-30a in DKD (0.874 ± 0.254, p = 0.079) and FSGS (1.378 ± 0.312, p < 0.0006)). Hsa-mir-193a exhibited significant dysregulation in DKD (1.017 ± 0.413, p < 0.029) but not in FSGS (4.18 ± 1.528, p = 0.058). Hsa-mir-196a and hsa-mir-200a showed upregulation in patient groups (hsa-mir-196a in DKD (1.278 ± 0.527, p = 0.074) and FSGS (2.47 ± 0.911, p < 0.0003); hsa-mir-200a in DKD (1.909 ± 0.825, p = 0.082) and FSGS (1.301 ± 0.358, p < 0.008)).

Conclusion

Specific miRNAs, particularly miR-21, miR-30a, miR-196a, and miR-200a, might play a role in the pathogenesis of kidney diseases and could potentially serve as biomarkers to distinguish between FSGS and DKD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulosclerosis, Focal SegmentalMicroRNAsDiabetic NephropathiesExosomesHumansMaleFemaleMiddle AgedAdultDiagnosis, DifferentialCross-Sectional StudiesBiomarkersCase-Control StudiesGene Expression Profiling

Substanzen

MicroRNAsMIRN193 microRNA, humanMIRN21 microRNA, humanBiomarkersMIRN196 microRNA, humanMIRN200 microRNA, humanMIRN30a microRNA, human

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Technical University, Istanbul, Turkey.
  • Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
  • Division of Nephrology, Bagcilar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Division of Nephrology, Kartal Lutfi Kirdar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Tissue Typing Laboratory, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.

ORCID-Profile: Sinan Trabulus

Förderung

  • Istanbul Üniversitesi-Cerrahpasa

Zitieren

APA

Trabulus, S., Zor, M. S., Alagoz, S., Dincer, M. T., Meşe, M., Yilmaz, E., Tahir Turanli, E., & Seyahi, N. (2024). Profiling of five urinary exosomal miRNAs for the differential diagnosis of patients with diabetic kidney disease and focal segmental glomerulosclerosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0312470

Vancouver

Trabulus S, Zor MS, Alagoz S, Dincer MT, Meşe M, Yilmaz E, et al. Profiling of five urinary exosomal miRNAs for the differential diagnosis of patients with diabetic kidney disease and focal segmental glomerulosclerosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0312470

BibTeX
@article{Trabulus2024,
  author = {Trabulus, Sinan and Zor, Mehmet Seyit and Alagoz, Selma and Dincer, Mevlut Tamer and Meşe, Meral and Yilmaz, Erkan and Tahir Turanli, Eda and Seyahi, Nurhan},
  title = {Profiling of five urinary exosomal miRNAs for the differential diagnosis of patients with diabetic kidney disease and focal segmental glomerulosclerosis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0312470}
}
Kostenlos starten →